Tech Company Financing Transactions

HDL Therapeutics Funding Round

HDL Therapeutics closed a $1.5 million investment round on 9/15/2016. Investors included private investors.

Transaction Overview

Company Name
Announced On
9/15/2016
Transaction Type
Venture Equity
Amount
$1,486,610
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 13 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
46701 Commerce Center Dr.
Plymouth, MI 48170
USA
Website
Email Address
Not Recorded
Overview
We are a privately held cardiovascular device company and a leader in the field of reversing coronary atherosclerosis. Our innovative acute care therapeutic device called PDS-2� System transforms a patient's own plasma into an atherosclerostic reversal agent using our patented technology.
Profile
HDL Therapeutics LinkedIn Company Profile
Social Media
HDL Therapeutics Company Twitter Account
Company News
HDL Therapeutics News
Facebook
HDL Therapeutics on Facebook
YouTube
HDL Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Roger Newton
  Roger Newton LinkedIn Profile  Roger Newton Twitter Account  Roger Newton News  Roger Newton on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/15/2016: Packet venture capital transaction
Next: 9/15/2016: Vertebrae venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document tech company VC transactions. VC investment data records on this site are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary